NovaBay Pharmaceuticals, Inc. (NBY) Starts Presentation at the 8th Annual LD Micro Invitational
NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX® family of products and the AGANOCIDE® compounds. The Neutrox family of products includes AVENOVA® for the eye care market, NEUTROPHASE® for wound care market, and CELLERX® for the aesthetic dermatology market. The Aganocide compounds, still under development, have target applications in the dermatology and urology markets. For more information, visit the company’s website at www.NovaBay.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access…







